Newsletters, Scientific Conferences &

Publications

Stay up to date on CCRAN news and recent advancements in oncology, as CCRAN continues to contribute to the colorectal cancer medical journals and scientific discussions.

winter 2023
summer 2022
winter 2022
summer 2021
spring 2021
november 2020

BIOMARKERS CONFERENCE 2024

Precision medicine is transforming cancer care, but timely and equitable access remain significant barriers. CCRAN is dedicated to overcoming these challenges and ensuring that metastatic cancer patients have access to advanced biomarker testing results. CCRAN's 2024 Biomarker Conference was built on the outcomes of the 2023 inaugural Conference. Over the course of two days, the Conference once again convened clinical, research, policy and patient experts from across multiple cancer types to delve deeper into the access issues in Canada.

EAOC SYMPOSIUM 2023

Since the 1990s, an increase in the incidence of early-onset cancers has been documented globally. Upward trends in early onset cancer diagnosis are documented across different cancer types, including breast, prostate, thyroid, colon, esophagus, kidney, liver, and pancreas. The most common cancers vary by age group and sex. Lead authors of the publication of early- onset cancer an emerging global epidemic? Current evidence and future implications (Nature Reviews Clinical Oncology, September 2022, 19(10):1-18) will deliver findings from their research and perspectives on the global trends in early-onset cancer from their clinical experience. The symposium will present key findings that highlight the importance of early colorectal cancer screening, particularly in young adults whose symptoms may present differently. Speakers will also elaborate on progress, in terms of new evidence in support of earlier screening, over the past year.A catalyst for transforming health systems and person-centred care: Canadian national position statement on patient-reported outcomes

BIOMARKER CONFERENCE 2023

Precision medicines are guided by a tumor's biomarker status and represent a tremendous advancement in cancer treatment. They offer new hope, but systemic barriers to accessing biomarker testing and results need to be addressed. CCRAN's 2023 Conference focused not only on biomarker testing, but also on the utility of CGP and ctDNA testing to improve patient outcomes in Canada.

EAOCRC SYMPOSIUM 2022

The symposium will present key findings that highlight the importance of early colorectal cancer screening, particularly in young adults whose symptoms may present differently. Speakers will also elaborate on progress, in terms of new evidence in support of earlier screening, over the past year.A catalyst for transforming health systems and person-centred care: Canadian national position statement on patient-reported outcomes

ccran newsletters 4

BMC Cancer

What are the experiences of colorectal cancer patients with biomarker testing in Canada?: a mixed methods study

ccran newsletters 4

CURRENT ONCOLOGY

Addressing the Rising Trend in Early-Age-Onset Cancers in Canada

ccran newsletters 4ccran newsletters 4

CURRENT ONCOLOGY

Barriers and Unequal Access to Timely Molecular Testing Results: Addressing the Inequities in Cancer Care Delays across Canada

national cancer

CURRENT ONCOLOGY

Breaking Down Barriers to Detection and Care in Early-Age-Onset Colorectal Cancer in Canada

ccran newsletters

CURRENT ONCOLOGY

Early-Age-Onset Colorectal Cancer in Canada: Evidence, Issues and Calls to Action

ccran newsletters3

CURRENT ONCOLOGY

A catalyst for transforming health systems and person-centred care: Canadian national position statement on patient-reported outcomes

ccran newsletters

CURRENT ONCOLOGY

Attitudes of Canadian Colorectal Cancer Care Providers towards Liver Transplantation for Colorectal Liver Metastases: A National Survey